Benzinga | Nov 5, 2021 09:24AM EDT

Global Blood Therapeutics Q3 EPS $(1.13) Misses $(1.11) Estimate, Sales $52.05M Miss $53.70M Estimate

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(1.13) per share which missed the analyst consensus estimate of $(1.11) by 1.8 percent. This is a 16.49 percent decrease over losses of $(0.97) per share from the same period last year. The company reported quarterly sales of $52.05 million which missed the analyst consensus estimate of $53.70 million by 3.07 percent. This is a 41.10 percent increase over sales of $36.89 million the same period last year.